Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: United Therapeutics Corporation, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
United Therapeutics Corporation June 26, 202698.0%
-
United Therapeutics Corporation June 26, 202597.9%
-
United Therapeutics Corporation June 26, 202497.4%
-
United Therapeutics Corporation June 26, 202394.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 14, 2026 | United Therapeutics Corporation | Option exercise | +130 | $110.86 | $14,412 |
| Sep 14, 2026 | United Therapeutics Corporation | Open-market sale | −130 | $505.79 | $65,753 |
| Sep 14, 2026 | United Therapeutics Corporation | Open-market sale | −98 | $505.98 | $49,586 |
| Jul 9, 2026 | United Therapeutics Corporation | Option exercise | +650 | — | — |
| May 12, 2026 | United Therapeutics Corporation | Open-market sale | −258 | $581.94 | $150,141 |
| Dec 9, 2025 | United Therapeutics Corporation | Open-market sale | −187 | $481.63 | $90,065 |
| Jul 25, 2025 | United Therapeutics Corporation | Option exercise | +590 | — | — |
| Jun 24, 2025 | United Therapeutics Corporation | Open-market sale | −645 | $289.99 | $187,044 |
| Dec 30, 2024 | United Therapeutics Corporation | Open-market sale | −255 | $355.77 | $90,721 |
| Nov 8, 2024 | United Therapeutics Corporation | Open-market sale | −224 | $412.28 | $92,351 |
| Jul 13, 2024 | United Therapeutics Corporation | Option exercise | +900 | — | — |
| Jun 25, 2024 | United Therapeutics Corporation | Open-market sale | −266 | $318.58 | $84,742 |
| Mar 27, 2024 | United Therapeutics Corporation | Open-market sale | −325 | $237.80 | $77,285 |
| Dec 19, 2023 | United Therapeutics Corporation | Open-market sale | −605 | $244.90 | $148,165 |
| Sep 13, 2023 | United Therapeutics Corporation | Open-market sale | −383 | $222.36 | $85,164 |
Questions about Nilda Mesa
What boards is Nilda Mesa on?
Nilda Mesa sits on the board of United Therapeutics Corporation.
How long has Nilda Mesa served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.